Navigation Links
Angeion Selects Hendrik Struik for Board of Directors
Date:4/24/2012

medical device manufacturers, clinical research organizations, health and fitness clubs, personal training studios, and other exercise facilities. For more information about Angeion, visit www.angeion.com.

 

Forward Looking Statements  Press releases and other statements by Angeion may contain forward-looking statements about Angeion's future financial results and business prospects that by their nature involve substantial risks and uncertainties.  You can identify these statements by the use of words such as "anticipate," "believe," "estimate," "expect," "project," "intend," "plan," "will," "target," and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or business plans or prospects.  Our actual results may differ materially depending on a variety of factors including: (1) national and worldwide economic and capital market conditions; (2) continuing cost-containment efforts in our hospital, clinic, and office markets; (3) remaining as a qualified provider for large group purchasing organizations, thereby ensuring continued access to our market and efficiently increasing our sales potential to expanded numbers of companies using these buying groups; (4) any changes in the patterns of medical reimbursement that may result from national healthcare reform; (5) our ability to successfully operate our business, including successfully converting our increasing research and development expenditures into new and improved cardiorespiratory diagnostic products and services and selling these products and services under the MedGraphics and New Leaf brand names into existing and new markets; (6) our ability to complete our software development initiatives and migrate our MedGraphics and New Leaf platforms to a next generation technology; (7) our ability to maintain our cost structure at a level that is appropriate to our near to mid-te
'/>"/>

SOURCE Angeion Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Angeion Corporation to Report Third Quarter Fiscal Year 2011 Financial Results on Thursday, September 1, 2011
2. Angeion Corporation Reports Third Quarter Fiscal 2011 Operating Results
3. Angeion Corporation to Report Fourth Quarter and Fiscal Year 2011 Financial Results on Friday, December 16, 2011
4. Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results
5. Angeion Corporation to Report First Quarter Fiscal 2012 Financial Results on Tuesday, February 28, 2012
6. Angeion Corporation Reports First Quarter Fiscal Year 2012 Operating Results
7. Wendy D. Lynch, Ph.D., Joins Angeions Board of Directors
8. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
9. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
10. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
11. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... NEW YORK , March 31, 2015 ... ) announced today that it intends to expand its ... fully human monoclonal antibody targeting eotaxin-1. Bullous Pemphigoid is ... approximately 60,000 patients in the US and ... expects to start enrolling patients in a Phase II ...
(Date:3/31/2015)... , March 31, 2015   Unique Pharmaceuticals , ... is complete and the company has initiated sterile compounding ... "Our goal as a company is to meet and ... Leeah . "Meeting the new regulations is validation of ... embracing the future of our industry, investing in its ...
(Date:3/31/2015)... , Mar. 27, 2015 Research and Markets ... addition of the "North American Laboratory Information ... System), by Type (Clinical Pathology Laboratory Information System, ... 2019" report to their offering. ... estimated to grow at a CAGR of 7.8% ...
Breaking Medicine Technology:Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 2Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 3Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 4Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 2Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 3North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 2North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 3
... cherry tree saplings were planted in Central Park of ... County Park System, located in Parsippany Troy-Hills.  The planting ... 100th anniversary of the historic gift of Japanese flowering ...  More than 75 Daiichi Sankyo employee volunteers partnered with ...
... Romark Laboratories announced that results of a large ... drug, NT-300 (nitazoxanide), will be presented as an oral ... Infectious Diseases Society of America (IDSA) being held in ... The clinical trial enrolled 624 patients at ...
Cached Medicine Technology:Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey 2Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey 3Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey 4Romark Announces Clinical Trial Results for New Influenza Drug Presented at IDSA Meeting 2011 2Romark Announces Clinical Trial Results for New Influenza Drug Presented at IDSA Meeting 2011 3Romark Announces Clinical Trial Results for New Influenza Drug Presented at IDSA Meeting 2011 4Romark Announces Clinical Trial Results for New Influenza Drug Presented at IDSA Meeting 2011 5Romark Announces Clinical Trial Results for New Influenza Drug Presented at IDSA Meeting 2011 6Romark Announces Clinical Trial Results for New Influenza Drug Presented at IDSA Meeting 2011 7
(Date:3/31/2015)... 31, 2015 As the scientific community ... Balance Network (GEBN) is poised to make meaningful ... health. GEBN is a network of scientists from ... Asia and Oceania who have banded together to further ... the body (energy balance) and apply this understanding to ...
(Date:3/31/2015)... Williams Comfort Air knows people ... their home comfort is at stake. In order ... fit into the customer’s schedule, a new online ... at requested times. , To take advantage ... the Indianapolis area can visit http://williamscomfortair.com/services-maintenance/schedule-online/ , ...
(Date:3/31/2015)... 2015 Tickets are now on sale ... tradition since 1973. The 2015 Spring production, Fairy Tales ... Ice. On April 24 in partnership with the Alzheimer's ... night tribute to the Pat Bowlen family, long-time partners ... the opening event proceeds will go to the Alzheimer's ...
(Date:3/31/2015)... 2015 Fitbody Personal Training LLC invites participants ... night or Saturday morning workouts away from the gym and ... from FitBody Personal Training LLC. The classes are moving outdoors. ... Grashof, offers boot camp outdoors on Thursday evenings starting April ... for this next session starts on April 11th and ends ...
(Date:3/31/2015)... TX (PRWEB) March 31, 2015 ... Practice Edition 2, bringing the industry’s most advanced ... the healthcare community. Physicians can now experience the ... a trusted source, offering value-added support services that ... (EHR) systems. , “QMedET is proud to provide ...
Breaking Medicine News(10 mins):Health News:Global Energy Balance Network Experts from Six Continents Join Forces to Reduce Obesity, Including the University of Colorado Anschutz Health and Wellness Center's James O. Hill, PhD 2Health News:Global Energy Balance Network Experts from Six Continents Join Forces to Reduce Obesity, Including the University of Colorado Anschutz Health and Wellness Center's James O. Hill, PhD 3Health News:Williams Comfort Air Launches Online Scheduling Tool to Indianapolis-Area Home and Business Owners 2Health News:FitBody Personal Training LLC Announces its Personal Training Classes are Moving Outdoors 2Health News:QMedET Solutions Announces Addition of Dragon® Medical Practice Edition 2 to its Roster of Products 2
... imaging technology is expected to help physicians better classify ... cleared by the FDA that allows doctors to ... This new technique may significantly reduce the need for ... 20 percent of biopsies turn up positive for cancer. ...
... California Alliance for Inclusive Communities (CAIC) has recently joined ... They join the majority of state and national disability ... an advocacy group that works on behalf of groups ... ,Just as a new national AP/Ipsis poll was ...
... and Chembio Diagnostics, Inc. (OTC Bulletin Board: CEMI) ... agreements for the development of rapid diagnostic tests ... by IDRI. The tests will be developed by ... platform (DPP(TM)) and will incorporate IDRI's proprietary antigens. ...
... Council announces the launch of Global Health TV, a ... experts and civil society on the major health issues ... service is a collaborative project between HBL Media, a ... Global Health TV website, http: www.globalhealthtv.com, will bring viewers ...
... tend to lose muscle mass and grow frail? One important ... the elderly to respond to the muscle-building stimulus of the ... its link to diabetes a condition in which either ... hormone's activity (as in type 2 diabetes) causes blood sugar ...
... risk factors beyond those expected from weight loss in ... due to the drug itself, reports an article in ... ,Advertisements for rimonabant (sold under the ... 50% of the effects on cardiometabolic risk factors ...
Cached Medicine News:Health News:IDRI and Chembio to Develop Tests for Leishmaniasis and Leprosy 2Health News:IDRI and Chembio to Develop Tests for Leishmaniasis and Leprosy 3Health News:Aerobic Exercise Helps Maintain Muscle in Elderly: Research 2Health News:Anti-obesity Drugs Claimed Additional Benefits on cardiometabolic Risk Factors Questioned 2
MagaCell-Streptavidin is a streptavidin coupled to magnetizable cellulose/iron oxide particles...
For general purposes...
Streptavidin A-Beads are polydisperse 1.8 m paramagnetic particles covalently coupled with streptavidin. The paramagnetic particles remain in solution over extended periods of time. Mixing is require...
... method for isolating antibodies, antigens, lectins, ... affinity binding, while retaining biological activity. ... particles to separate biotinylated molecules from ... Beads from the suspension, an external ...
Medicine Products: